Search Results

Influenza is a common, highly contagious infection that can lead to life-threatening complications. Learn more about influenza and our cutting-edge vaccines.

https://www.seqirus.us/expertise/influenza

Seqirus brings multifaceted expertise to influenza prevention, employing both egg and cell-based technologies to meet the global community's needs.

https://www.seqirus.us/expertise

Seqirus is a world leader in developing and producing influenza vaccines. Learn more about how we work with our partners to protect the global community.

https://www.seqirus.us/products

New Data Supports the Effectiveness of Adjuvanted Seasonal Influenza Vaccine in Reducing Influenza-Related Hospitalizations and Healthcare Costs in Older Adults

https://www.seqirus.us/news/seqirus-presents-new-data-at-eswi-8th-virtual-conference

Renewal reaffirms longstanding, public-private partnership between Seqirus and the Biomedical Advanced Research and Development Authority (BARDA)

https://www.seqirus.us/news/seqirus-and-us-gov-renew-multi-year-agreement-for-influenza-pandemic-preparedness-and-response

New facility in Waltham, Massachusetts, will support CSL’s growing R&D portfolio, including the self-amplifying mRNA technology platform.

https://www.seqirus.us/news/seqirus-announces-new-facility-supporting-research-and-development-of-influenza-vaccine-technology

Results suggest that QIVc was more effective than QIVe at preventing IRMEs in both populations, with fewer documented IRMEs in children and adults.

https://www.seqirus.us/news/seqirus-presents-evidence-of-seasonal-influenza-vaccine-effectiveness-at-isirv

Update on CDC Advisory Committee on Immunization Practices (ACIP) Review of Enhanced Influenza Vaccines for Adults 65+

https://www.seqirus.us/news/update-on-cdc-advisory-committee-immunization-practices-review-enhanced-flu-vaccines-adults-65-plus

Seqirus announces data supporting the effectiveness of both cell-based and adjuvanted seasonal influenza vaccines from two real-world studies conducted during the 2019/2020 influenza season in the U.S.

https://www.seqirus.us/news/seqirus-presents-new-rwe-flu-vaccines-at-idweek

Seqirus has been on the front line of pandemic preparedness for more than a century. Learn more about our rapid vaccine production capabilities.

https://www.seqirus.us/expertise/influenza/pandemic-response-solutions